CytomX Therapeutics (CTMX) Q3 2026 Earnings

6AugConfirmed
Q4 2025
Q1 2026
Next
Next
-0.17
-0.13
-0.09
-0.05

Details

Expected EPS
-0.081649
Actual EPS
N/A
Surprise EPS
0.08
Surprise Percent
+100%

Description

CytomX Therapeutics (CTMX) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts